Vector systems for prenatal gene therapy: principles of adenovirus design and production

Alba, R., Baker, A. H. and Nicklin, S. (2012) Vector systems for prenatal gene therapy: principles of adenovirus design and production. In: Coutelle, C. and Waddington, S. N. (eds.) Prenatal Gene Therapy: Concepts, Methods, and Protocols. Series: Methods and protocols (891). Humana Press: Totowa, NJ, pp. 55-84. ISBN 9781617798726 (doi: 10.1007/978-1-61779-873-3_4)

Full text not currently available from Enlighten.


Adenoviruses have many attributes, which have made them one of the most widely investigated vectors for gene therapy applications. These include ease of genetic manipulation to produce replication-deficient vectors, ability to readily generate high titer stocks, efficiency of gene delivery into many cell types, and ability to encode large genetic inserts. Recent advances in adenoviral vector engineering have included the ability to genetically manipulate the tropism of the vector by engineering of the major capsid proteins, particularly fiber and hexon. Furthermore, simple replication-deficient adenoviral vectors deleted for expression of a single gene have been complemented by the development of systems in which the majority of adenoviral genes are deleted, generating sophisticated Ad vectors which can mediate sustained transgene expression following a single delivery. This chapter outlines methods for developing simple transgene over expressing Ad vectors and detailed strategies to engineer mutations into the major capsid proteins.

Item Type:Book Sections
Glasgow Author(s) Enlighten ID:Nicklin, Professor Stuart and Baker, Professor Andrew and Alba, Dr Raul
Authors: Alba, R., Baker, A. H., and Nicklin, S.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Publisher:Humana Press

University Staff: Request a correction | Enlighten Editors: Update this record